MENS
Jyong Biotech Ltd. Ordinary Shares
NASDAQ · Healthcare · Biotechnology · TW
$2.39
+5.29%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -7.30x
- Price / sales
- —
- Price / cash flow
- -59.75x
Enterprise value
- Enterprise value
- $199.1M
- EV / sales
- —
- EV / EBITDA
- -75.77x
- EV / EBIT
- -76.32x
- Market cap
- $181.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025